Pre-and perioperative inflammatory biomarkers in older patients resected for localized colorectal cancer: Associations with complications and prognosis

Troels Gammeltoft Dolin*, Ib Jarle Christensen, Astrid Zedlitz Johansen, Hans Jørgen Nielsen, Henrik Loft Jakobsen, Mads Falk Klein, Cecilia Margareta Lund, Stig Egil Bojesen, Dorte Lisbeth Nielsen, Benny Vittrup Jensen, Julia Sidenius Johansen

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

10 Citationer (Scopus)
24 Downloads (Pure)

Abstract

The association between pre-and perioperative inflammatory biomarkers, major compli-cations, and survival rates after resection of colorectal cancer (CRC) in older patients is largely unknown. The aim was to investigate age-dependent differences in these associations. Serum CRP, IL-6, and YKL-40 were measured preoperatively and on the first and second day after resection of CRC (stages I–III) in 210 older (≥70 years) and 191 younger patients (<70 years). The results from the complications was presented as an odds ratio (OR, with a 95% confidence interval (CI)) with logistic regression. Results from the mortality rates were presented as a hazard ratio (HR, with a 95% CI) using Cox proportional hazards regression. The preoperative inflammatory biomarkers were higher in the older vs. the younger patients. The risk of complications was increased in older patients with a high preoperative CRP (OR = 1.25, 95% CI 1.03–1.53), IL-6 (OR = 1.57, 95% CI 1.18–2.08), and YKL-40 (OR = 1.66, 95% CI 1.20–2.28), but not in younger patients. Mortality was higher in younger patients with high preoperative YKL-40 (HR = 1.66, 95% CI 1.06–2.60). This was not found in older patients. Elevated preoperative inflammatory biomarkers among older patients were associated with an increased risk of complications, but not mortality. Preoperative inflammatory biomarkers may be useful in assessing the risk of a complicated surgical course in older patients with CRC.

OriginalsprogEngelsk
Artikelnummer161
TidsskriftCancers
Vol/bind14
Udgave nummer1
Antal sider21
ISSN2072-6694
DOI
StatusUdgivet - 1 jan. 2022

Bibliografisk note

Funding Information:
This research was funded by VELUX foundation (Grant project number 00018310) (salary to TGD and CML), and the Beckett Foundation (grant project number 19-2-4330) (YKL-40 ELISA kits). APC funded by Herlev and Gentofte Hospital.

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Citationsformater